11 Sep 2012, BioSpectrum Bureau , BioSpectrum
Singapore: Maxillent, a company dedicated to innovative solutions for dental implants, signed an exclusive contract with Pioneer Richteeth Medical Distribution Company, Shanghai, for the distribution of the iRaise Sinus Lift Implant in Hong Kong. The pre-launch event of iRaise was hosted jointly by Maxillent and Pioneer in the Hong Kong Dental Implant Surgical Center (DISC).
iRaise solves a key difficulty in implant surgery, which involves the highly invasive and traumatic sinus lift procedure required in 20 percent of dental implant cases when there is insufficient bone in the upper jaw to support implants. The current sinus lift procedure requires over an hour of invasive surgery and causes significant trauma. Patients require three-to-10 days of home rest and complain of significant swelling and bruising.
iRaise provides a minimally invasive alternative to the sinus lift. The technology is based on a unique dental implant with an internal channel, which allows the dentist to perform a sinus lift using a simple hydraulic method. For the dentist, the procedure significantly reduces chair time, complications and post-operative care. For patients, iRaise offers vastly reduced discomfort and recovery time, eliminates facial swelling and bruising, and prevents lost-work days.
"We are excited to expand the availability of iRaise to APAC markets," says Mr Gideon Fostick, CEO, Maxillent. "We have chosen Pioneer as the ideal partner for our first entry into Asia. They have the expertise and reach that we were looking for in Hong Kong and in additional Asian markets."
"Maxillent's technology for minimally invasive sinus lifts is very well suited to the Hong Kong market, where dentists want to provide patients with the best possible experience," says Mr Vincent Yuen, MD, Pioneer Dental Division.